An interventional study of Cognitive Behavior Therapy for Chronic Pelvic Pain-CBT-cp in Chronic Pelvic Pain Syndrome, sponsored by Islamia University of Bahawalpur. Not yet recruiting. Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2024-06-06.
Sponsored by Islamia University of Bahawalpur · Not applicable, Interventional, and Treatment
This will be the pilot study trial. The target population will be 30 individuals with Chronic Pelvic Pain (CCP). There will be 02 groups, Experimental Group and Control Group. The primary outcome measure will be Impact of Female Chronic Pelvic Pain Questionnaire (IF-CPPQ). The experimental group will receive CBT spread over 12 sessions.
375 studies on the registry are indexed under Pelvic Pain; 83 are open to participants now.
This study's planned enrollment of 60 is above the median of 54 across 273 interventional studies indexed under Pelvic Pain.
Browse Pelvic Pain studies →Islamia University of Bahawalpur is the lead sponsor of 15 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
It will receive 12 sessions of Cognitive Behavior Therapy for Chronic Pelvic Pain.
Behavioral: Cognitive Behavior Therapy for Chronic Pelvic Pain-CBT-cp
Group B will be control group.
CBT-cp will be administered weekly sessions for 12 weeks.
Impact of Female Chronic Pelvic Pain Questionnaire (IF-CPPQ)
Impact of Female Chronic Pelvic Pain Questionnaire (IF-CPPQ)
Time frame: Up to 16 weeks
No study locations are listed for this record.
Plan to share: Yes
Supporting information: Study protocol
No publications or documents are linked to this record.
This study is not yet recruiting, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Islamia University of Bahawalpur